Valeant Pharmaceuticals Intl Inc.: 3 Lessons From Bill Ackman’s Painful Experience

Bill Ackman has made mistakes with Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) that the rest of us can learn from.

| More on:
The Motley Fool

As Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) shares continue to plunge, activist investor Bill Ackman of Pershing Square Capital Management continues to stick by the company. He’s even bought more shares along the way, costing Pershing’s clients a ton of money.

To be fair to Mr. Ackman, he is still a widely respected investor, and for good reason. He has had a number of big successes, including the turnaround at Canadian Pacific Railway Limited, which has been a big win for shareholders of that company.

But much of his suffering with Valeant was avoidable, and there are some very valuable lessons we can all learn along the way.

1. Don’t hesitate to put stocks in the “too hardpile

Valeant has always been a difficult stock to analyze for a number of reasons. First of all, the company has been a serial acquirer for years, which makes it difficult to compare different time periods. On top of that, Valeant emphasizes non-GAAP measures in its financial reporting, such as “cash earnings per share,” which exclude some very legitimate costs. And if that wasn’t enough, sales data for individual drugs isn’t always provided.

Then when skeptics such as Andrew Left, Robby Boyd, and John Hempton started exposing Valeant’s seedy underbelly, the story got even more complicated. At this point, knowing what was going on at Valeant became impossible to figure out. And the company’s future became even more unclear.

At this point, Valeant deserved a place on the “too hard” pile, meaning the stock was too complicated to figure out, and thus too complicated to own. There’s nothing wrong with thinking this way, and anyone who did would have saved a lot of money on this stock, including Mr. Ackman.

2. Don’t be too concentrated

Most fund managers keep too many holdings in their portfolios, meaning they end up owning low-conviction ideas. But Mr. Ackman only has eight long holdings, meaning that any mistakes have a big impact on overall returns.

For an individual investor, this isn’t always such a big deal. But in Mr. Ackman’s case, when a stock moves against him, Wall Street starts speculating that he’ll have to reverse his bets to deal with fund redemptions or margin calls. This causes his positions to move further in the wrong direction.

For example, we’ve seen Herbalife Ltd. shares increase throughout this whole saga, feeding a vicious cycle for Mr. Ackman. This wouldn’t have happened if he were properly diversified.

3. Admit your mistakes

Admitting mistakes is never an easy thing to do, especially while investing. In Mr. Ackman’s case, it may be even harder simply because he has had so much success in the past.

We’ve seen other successful investors unable to admit mistakes. Bill Miller clung to financial stocks as the financial crisis unfolded. Eric Sprott stuck too much to junior mining companies. Like Mr. Ackman, both of these people may have been a victim of their past success.

As for the rest of us, when a stock moves in a big way against us, we must re-evaluate our position. And that means asking a very simple question: “If I didn’t already own the stock, would I buy it?” If the answer is no, then it’s time to sell.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Benjamin Sinclair has no position in any stocks mentioned.  Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

Plane on runway, aircraft
Stocks for Beginners

Up 53% From its 52-Week Low, Is Cargojet Stock Still a Buy?

Cargojet (TSX:CJT) stock is up a whopping 53%, nearing closer to 52-week highs from 52-week lows, so what's next for…

Read more »

Question marks in a pile
Bank Stocks

Should You Buy Canadian Western Bank for its 4.8% Dividend Yield?

Down 35% from all-time highs, Canadian Western Bank offers a tasty dividend yield of 4.8%. Is the TSX bank stock…

Read more »

Gold bars
Metals and Mining Stocks

Why Alamos Gold Jumped 7% on Wednesday

Alamos (TSX:AGI) stock and Argonaut Gold (TSX:AR) surged after the companies announced a friendly acquisition for $325 million.

Read more »

tsx today
Stock Market

TSX Today: Why Record-Breaking Rally Could Extend on Thursday, March 28

The main TSX index closed above the 22,000 level for the first time yesterday and remains on track to post…

Read more »

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »